Product Data Sheet

Ibrutinib impurity 14

Catalog No. A99431

main product photo
Ibrutinib Impurity 14 is a structural impurity associated with Ibrutinib, a selective inhibitor of Bruton's tyrosine kinase (BTK). This compound is utilized primarily in quality control and validation studies of Ibrutinib formulations. It serves as an important reference standard for assessing the purity and consistency of drug substances in pharmaceutical development.
Chemical Information
Catalog NumA99431
M. Wt472.54
FormulaC26H28N6O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2031255-26-0
Synonyms
SMILESO=C(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)CCOC
Biological Activity
DescriptionIbrutinib Impurity 14 is a structural impurity associated with Ibrutinib, a selective inhibitor of Bruton's tyrosine kinase (BTK). This compound is utilized primarily in quality control and validation studies of Ibrutinib formulations. It serves as an important reference standard for assessing the purity and consistency of drug substances in pharmaceutical development.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.